Archive for April 7th, 2012

Vaccine Scares Could Become More Common, Experts Say | MyHealthNewsDaily.com

7 April, 2012

Via Scoop.itVirology News

“Vaccine scares that lead portions of the population to forgo vaccination could become more common as more diseases become eradicated.”

 

This is becoming a major problem for developed countries – that is to say, high GDP countries where people mostly have jobs and houses and electricity, and TV – and of course, that bringer of disinformation about vaccines, the internet.

 

Seriously: there are some 300 000 ANTI-vaccine sites out there, according to contacts in the USA, and some of them are so rabid they would make neo-nazis look respectable.

 

As I have written elsewhere – in a comment on an article in The Scientist – it would be ironic if developing countries started instituting stricter vaccination controls for travellers from the more affluent world.  It is coming, though: the first importations of diseases like measles from Europe to the Americas have already occurred, and I am sure the incidence of these reports will rise as vaccine paranoia grows.

Via www.myhealthnewsdaily.com

Sex and oral cancer: What is the connection? – DentistryIQ

7 April, 2012

Via Scoop.itVirology News

Are sexual relations closely intertwined with oral health? Jo-Anne Jones, RDH, addresses that question by sharing some of the latest statistics regarding a possible connection between the human papillomavirus (HPV) and oral cancer.

Via www.dentistryiq.com

Study Explains How the First Successful HIV Vaccine Worked | Healthland | TIME.com

7 April, 2012

Via Scoop.itVirology News

In 2009, researchers reported that an AIDS vaccine had for the first time protected people against HIV. Since then, the researchers have been wondering, How did it work?

AIDS researchers have only been able to guess at what these critical weapons against HIV could be, which is partly why their efforts to create a vaccine have thus far been marked by a long line of failed attempts. But when the RV144 trial in Thailand showed promise in 2009, scientists finally had something to work with. The vaccine was only modestly effective — protecting just 31% of heterosexual adults from infection — especially compared with inoculations against other common infectious agents like measles or mumps, which are 95% to 98% effective. But it was a start.

 

Ummmmm…yes.  Well – sort of.  The vaccine was only marginally effective, and my opinion is that it may not have very much to say to us at all.

 

 

Via healthland.time.com

Trials Show Promise Of Human Virus To Treat Head And Neck Cancer Patients

7 April, 2012

Via Scoop.itVirology News

A naturally-occurring harmless human virus may be able to boost the effects of two standard chemotherapy drugs in some cancer patients, according to early stage trial data published in Clinical Cancer Research.

RT3D, trade name Reolysin, is a new drug developed by Oncolytics Biotech Inc with preclinical and clinical studies conducted at The Institute of Cancer Research (ICR) and The Royal Marsden Hospital. It is based on a virus (reovirus type 3 Dearing) that is found in almost all adults’ respiratory and gastrointestinal tracts without causing any symptoms.

 

Reoviruses rule….

Via www.medicalnewstoday.com


Follow

Get every new post delivered to your Inbox.

Join 436 other followers